“This powerful new tool will enable public health scientists in research establishments, public health agencies, healthcare services, and diagnostic companies around the world to help further understanding of infectious diseases, starting with the coronavirus,” said Derrick Crook, Professor of Microbiology in the Nuffield Department of Medicine at the University of Oxford.

The collaboration aims to deliver a global, borderless jurisdiction in which companies can establish, transact and succeed internationally whilst avoiding the increasing boundaries, borders and tariffs of our deglobalizing world.